541 related articles for article (PubMed ID: 26013578)
1. Pre-conditioned place preference treatment of chloral hydrate interrupts the rewarding effect of morphine.
Sun Y; Zong W; Zhou M; Ma Y; Wang J
Pharmacol Biochem Behav; 2015 Aug; 135():60-3. PubMed ID: 26013578
[TBL] [Abstract][Full Text] [Related]
2. Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine.
Herzig V; Schmidt WJ
Neuropharmacology; 2004 Dec; 47(7):973-84. PubMed ID: 15555632
[TBL] [Abstract][Full Text] [Related]
3. Blockage of acquisition and expression of morphine-induced conditioned place preference in rats due to activation of glutamate receptors type II/III in nucleus accumbens.
Baharlouei N; Sarihi A; Komaki A; Shahidi S; Haghparast A
Pharmacol Biochem Behav; 2015 Aug; 135():192-8. PubMed ID: 26071679
[TBL] [Abstract][Full Text] [Related]
4. Blockade of micro-opioid receptors in the medial thalamus inhibits acquisition, but not expression, of morphine-induced conditioned place preference.
Guo N; Garcia MM; Taylor BK; Zadina JE; Harlan RE
Neuroscience; 2008 Feb; 151(4):948-54. PubMed ID: 18222040
[TBL] [Abstract][Full Text] [Related]
5. Melatonin reverses the expression of morphine-induced conditioned place preference through its receptors within central nervous system in mice.
Han J; Xu Y; Yu CX; Shen J; Wei YM
Eur J Pharmacol; 2008 Oct; 594(1-3):125-31. PubMed ID: 18706407
[TBL] [Abstract][Full Text] [Related]
6. Expression of morphine-conditioned place preference is more vulnerable than naloxone-conditioned place aversion to disruption by nociceptin in mice.
Sakoori K; Murphy NP
Neurosci Lett; 2008 Oct; 443(2):108-12. PubMed ID: 18662746
[TBL] [Abstract][Full Text] [Related]
7. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
8. Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed rats.
Herzig V; Schmidt WJ
Neurosci Lett; 2005 Feb; 374(2):119-23. PubMed ID: 15644276
[TBL] [Abstract][Full Text] [Related]
9. Facilitated extinction of morphine conditioned place preference with Tat-GluA2(3Y) interference peptide.
Dias C; Wang YT; Phillips AG
Behav Brain Res; 2012 Aug; 233(2):389-97. PubMed ID: 22633960
[TBL] [Abstract][Full Text] [Related]
10. Synthetic double-stranded RNA polyinosinic-polycytidylic acid augments morphine-induced conditioned place preference in rats.
Zhang L; Chen S; Liu H; Lu L; Zhai H
Behav Pharmacol; 2010 Jul; 21(4):369-73. PubMed ID: 20555252
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats.
Fujio M; Nakagawa T; Sekiya Y; Ozawa T; Suzuki Y; Minami M; Satoh M; Kaneko S
Eur J Neurosci; 2005 Dec; 22(11):2744-54. PubMed ID: 16324108
[TBL] [Abstract][Full Text] [Related]
12. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.
Cordery SF; Taverner A; Ridzwan IE; Guy RH; Delgado-Charro MB; Husbands SM; Bailey CP
Addict Biol; 2014 Jul; 19(4):575-86. PubMed ID: 23240906
[TBL] [Abstract][Full Text] [Related]
13. Opposite effects of MK-801 on the expression of food and morphine-induced conditioned place preference in rats.
Yonghui L; Xigeng Z; Yunjing B; Xiaoyan Y; Nan S
J Psychopharmacol; 2006 Jan; 20(1):40-6. PubMed ID: 16174676
[TBL] [Abstract][Full Text] [Related]
14. Surgical and pharmacological suppression of glucocorticoids prevents the enhancement of morphine conditioned place preference by uncontrollable stress in rats.
Der-Avakian A; Will MJ; Bland ST; Deak T; Nguyen KT; Schmid MJ; Spencer RL; Watkins LR; Maier SF
Psychopharmacology (Berl); 2005 May; 179(2):409-17. PubMed ID: 15821955
[TBL] [Abstract][Full Text] [Related]
15. The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats.
Ma YY; Guo CY; Yu P; Lee DY; Han JS; Cui CL
Exp Neurol; 2006 Aug; 200(2):343-55. PubMed ID: 16631172
[TBL] [Abstract][Full Text] [Related]
16. Nalbuphine is effective in decreasing the rewarding effect induced by morphine in rats.
Tao PL; Liang KW; Sung WY; Wu YT; Huang EY
Drug Alcohol Depend; 2006 Sep; 84(2):175-81. PubMed ID: 16517095
[TBL] [Abstract][Full Text] [Related]
17. Reinstatement of morphine-conditioned reward is blocked by memantine.
Popik P; Wrobel M; Bisaga A
Neuropsychopharmacology; 2006 Jan; 31(1):160-70. PubMed ID: 15886718
[TBL] [Abstract][Full Text] [Related]
18. Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine.
Shippenberg TS; Chefer VI; Thompson AC
Biol Psychiatry; 2009 Jan; 65(2):169-74. PubMed ID: 18950747
[TBL] [Abstract][Full Text] [Related]
19. Morphine conditioned place preference is attenuated by perinatal lead exposure.
Valles R; Cardon AL; Heard HM; Bratton GR; Nation JR
Pharmacol Biochem Behav; 2003 May; 75(2):295-300. PubMed ID: 12873619
[TBL] [Abstract][Full Text] [Related]
20. Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.
Narita M; Kishimoto Y; Ise Y; Yajima Y; Misawa K; Suzuki T
Neuropsychopharmacology; 2005 Jan; 30(1):111-8. PubMed ID: 15257306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]